Abstract
The drug 3,4-methylenedioxyethamphetamine ([MDE] also known as "Eve") is a less toxic analog of 3,4-methylenedioxymethamphetamine (also known as "Ecstasy") with similar psychotropic effects in humans. In a double-blind placebo-controlled, cross-over study we administered 140 mg of MDE or placebo orally to eight healthy male volunteers at 1:30 P.M. Serum cortisol, prolactin (PRL), and growth hormone (GH) levels, as well as blood pressure, and heart rate were measured every 20 minutes until 5:00 P.M. Administration of MDE was followed by statistically significant long-lasting increases of serum cortisol, PRL, systolic blood pressure, and heart rate, and by a trend toward blunting of GH secretion. The neuroendocrine and cardiovascular effects of MDE are comparable to those of other phenethyl-amines with the exception of the effect on GH secretion.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Additional information
Address reprint requests: Euphrosyne Gouzoulis, M.D., Department of Psychiatry, Medical Faculty of the RWTH, Pauwelsstrasse 30, D-5100, Aachen, Federal Republic of Germany.
Rights and permissions
About this article
Cite this article
Gouzoulis, E., Bardeleben, U., Rupp, A. et al. Neuroendocrine and Cardiovascular Effects of MDE in Healthy Volunteers. Neuropsychopharmacol 8, 187–193 (1993). https://doi.org/10.1038/npp.1993.20
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/npp.1993.20
Keywords
This article is cited by
-
Effects of MDMA, MDA and MDEA on blood pressure, heart rate, locomotor activity and body temperature in the rat involve α‐adrenoceptors
British Journal of Pharmacology (2006)
-
Acute poisoning with amphetamines (MDEA) and heroin: Antagonistic effects between the two drugs
Intensive Care Medicine (1996)